Genmab — Investor Relations & Filings
Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2024-02-14 | English | |
| 20-F | 2024-02-14 | English | |
| 6-K | 2024-02-14 | English | |
| Transaction in Own Shares 2024 | 2024-02-14 | English | |
| Genmab Announces Initiation of Share Buy-Back Program | 2024-02-14 | English | |
| Annual Report (ESEF) 2023 | 2024-02-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 12210749 | 6-K | 2024-02-14 | English | ||
| 12210750 | 20-F | 2024-02-14 | English | ||
| 12210751 | 6-K | 2024-02-14 | English | ||
| 1351512 | Transaction in Own Shares 2024 | 2024-02-14 | English | ||
| 12512440 | Genmab Announces Initiation of Share Buy-Back Program | 2024-02-14 | English | ||
| 1351530 | Annual Report (ESEF) 2023 | 2024-02-14 | English | ||
| 1351517 | Annual Report 2023 | 2024-02-14 | English | ||
| 12512441 | Genmab Publishes 2023 Annual Report | 2024-02-14 | English | ||
| 12210752 | SEC SCHEDULE 13G | 2024-02-08 | English | ||
| 12210754 | Major Shareholding Notification 2024 | 2024-02-02 | English | ||
| 12210753 | 6-K | 2024-01-31 | English | ||
| 12210755 | 6-K | 2024-01-23 | English | ||
| 1355959 | Earnings Release 2023 | 2024-01-23 | English | ||
| 12514774 | Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023 | 2024-01-23 | Danish | ||
| 12210756 | 6-K | 2024-01-23 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Genmab, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Genmab via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3365/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3365 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3365 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3365 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3365}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genmab (id: 3365)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.